Epilog

Epilog is a health care startup that aims to redefine care in life's last chapter. The company was founded to address a major human challenge – the way we manage the final stages of our lives, especially after receiving a life-threatening medical diagnosis. Epilog focuses on improving the quality of life and reducing the significant economic burden of poor decision-making at this stage, particularly the surge in hospital utilization rates in the last year of life. Epilog offers a patient-centric, holistic companion for individuals diagnosed with a life-limiting illness. The platform is supported by the world's leading behavioral and palliative experts, and it is designed with a deep understanding of behavioral principles. Epilog's solution actively assists individuals in managing their medical and life decisions in real-time, aiming to shift the focus from disease management to life management. As of now, there is no information available about the date of founding or the latest investment in Epilog. The startup is based in Israel, an emerging hub for innovation in the health care industry. Epilog's unique approach to addressing a critical aspect of healthcare makes it an intriguing prospect for potential venture capital investors looking to support innovative solutions that improve quality of life and reduce the economic burden in the healthcare sector.